Application supported by Phase 3 data reinforcing teclistamab regimens as a potential standard of care after at least one prior therapy1 Teclistamab monotherapy delivered superior progression-free ...

With rapid advances in AI, we now enter an era of automated risk remediation. Read about readiness to leverage agentic AI for ...

TAIZHOU CITY, ZHEJIANG PROVINCE, CHINA, March 3, 2026 /EINPresswire.com/ -- The global automotive mold industry has ...

Fintech Yendo is looking to triple application volume for its vehicle-secured credit card in 2026 after securing $200 million in recent ...

The National Auto Auction Association announced that its Warren Young, Sr. Scholastic Foundation is now accepting applications for its annual scholarships. The foundation will award up to 12 $10,000 ...

Skytrofa is administered as a once weekly injection. It comes as a powder in cartridges that you load into an auto-injector device. The dosage of Skytrofa will vary based on your age, weight, and ...

AstraZeneca said the U.S. Food and Drug Administration rejected an initial submission for its Saphnelo lupus drug in injection form, and vowed to work with the regulator to move forward with an ...

AstraZeneca AZN1.04%increase; green up pointing triangle said the U.S. Food and Drug Administration rejected an initial submission for its Saphnelo lupus drug in injection form, and vowed to work with ...

(RTTNews) - Eisai Co., Ltd. (ESALY, ESALF, 4523.T) and Biogen Inc. (BIIB) announced that the U.S. Food and Drug Administration has accepted for review Eisai's Supplemental Biologics License ...

The Furoscix on-body infusor. [Image courtesy of MannKind] MannKind (Nasdaq:MNKD) announced today that the FDA approved its Furoscix (furosemide) on-body infusor for pediatric patients. The company ...

DETROIT & BOSTON--(BUSINESS WIRE)--Sempresto, Inc., a medical device company pioneering smartphone integrated rescue drug delivery, today announced the acquisition of Alerje’s mobile device integrated ...